Metropolitan Life Insurance Company (MetLife)’s Q32 Bio QTTB Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-662	Closed	-$93.7K	–	2837
2021 Q3	$93.7K	Buy	+662	New	+$84.3K	﹤0.01%	2560
2021 Q2	–	Sell	-516	Closed	-$87.4K	–	2898
2021 Q1	$87.4K	Sell	516 -95	-16%	-$20K	﹤0.01%	2460
2020 Q4	$124K	Hold	611	–	–	﹤0.01%	2242
2020 Q3	$118K	Hold	611	–	–	﹤0.01%	2125
2020 Q2	$167K	Buy	611 +134	+28%	+$35.7K	﹤0.01%	1927
2020 Q1	$133K	Sell	477 -5	-1%	-$1.53K	﹤0.01%	1849
2019 Q4	$180K	Hold	482	–	–	﹤0.01%	1998
2019 Q3	$157K	Buy	482 +112	+30%	+$38.1K	﹤0.01%	2045
2019 Q2	$130K	Buy	370 +27	+8%	+$10.6K	﹤0.01%	2169
2019 Q1	$171K	Hold	343	–	–	﹤0.01%	2006
2018 Q4	$138K	Buy	+343	New	+$130K	﹤0.01%	2067

Other funds holding QTTB

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s QTTB Position: Q4 2021 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 662 shares — an estimated $93.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in QTTB in Q4 2018 and held it in 11 quarters. The position peaked at $180K in Q4 2019. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

Metropolitan Life Insurance Company (MetLife) reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 662 Q32 Bio shares in Q4 2021, an estimated $93.7K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Q32 Bio in Q4 2018 and held it in 11 quarters.
Metropolitan Life Insurance Company (MetLife)'s Q32 Bio position peaked at $180K in Q4 2019.
120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.